151 related articles for article (PubMed ID: 15122772)
1. The zonal distribution of megamitochondria with crystalline inclusions in nonalcoholic steatohepatitis.
Le TH; Caldwell SH; Redick JA; Sheppard BL; Davis CA; Arseneau KO; Iezzoni JC; Hespenheide EE; Al-Osaimi A; Peterson TC
Hepatology; 2004 May; 39(5):1423-9. PubMed ID: 15122772
[TBL] [Abstract][Full Text] [Related]
2. Pediatric non-alcoholic steatohepatitis: the first report on the ultrastructure of hepatocyte mitochondria.
Lotowska JM; Sobaniec-Lotowska ME; Bockowska SB; Lebensztejn DM
World J Gastroenterol; 2014 Apr; 20(15):4335-40. PubMed ID: 24764670
[TBL] [Abstract][Full Text] [Related]
3. Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction.
Richardson MM; Jonsson JR; Powell EE; Brunt EM; Neuschwander-Tetri BA; Bhathal PS; Dixon JB; Weltman MD; Tilg H; Moschen AR; Purdie DM; Demetris AJ; Clouston AD
Gastroenterology; 2007 Jul; 133(1):80-90. PubMed ID: 17631134
[TBL] [Abstract][Full Text] [Related]
4. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
[TBL] [Abstract][Full Text] [Related]
5. Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies.
Fassio E; Alvarez E; Domínguez N; Landeira G; Longo C
Hepatology; 2004 Oct; 40(4):820-6. PubMed ID: 15382171
[TBL] [Abstract][Full Text] [Related]
6. Electron microscopic findings in non-alcoholic fatty liver disease: is there a difference between hepatosteatosis and steatohepatitis?
Ahishali E; Demir K; Ahishali B; Akyuz F; Pinarbasi B; Poturoglu S; Ibrisim D; Gulluoglu M; Ozdil S; Besisik F; Kaymakoglu S; Boztas G; Cakaloglu Y; Mungan Z; Canberk Y; Okten A
J Gastroenterol Hepatol; 2010 Mar; 25(3):619-26. PubMed ID: 20370732
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis markers in liver biopsy of nonalcoholic steatohepatitis in pediatric patients.
Valva P; De Matteo E; Galoppo M; Pedreira A; Giacove G; Lezama C; Marco I; Galoppo MC; Preciado MV
Hum Pathol; 2008 Dec; 39(12):1816-22. PubMed ID: 18715620
[TBL] [Abstract][Full Text] [Related]
8. End-stage nonalcoholic fatty liver disease: evaluation of pathomorphologic features and relationship to cryptogenic cirrhosis from study of explant livers in a living donor liver transplant program.
Nayak NC; Vasdev N; Saigal S; Soin AS
Hum Pathol; 2010 Mar; 41(3):425-30. PubMed ID: 19954815
[TBL] [Abstract][Full Text] [Related]
9. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
Ong JP; Elariny H; Collantes R; Younoszai A; Chandhoke V; Reines HD; Goodman Z; Younossi ZM
Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462
[TBL] [Abstract][Full Text] [Related]
10. Hepatic stellate cell activation in nonalcoholic steatohepatitis and fatty liver.
Washington K; Wright K; Shyr Y; Hunter EB; Olson S; Raiford DS
Hum Pathol; 2000 Jul; 31(7):822-8. PubMed ID: 10923919
[TBL] [Abstract][Full Text] [Related]
11. Liver biopsy in alcoholic and non-alcoholic steatohepatitis patients.
Tiniakos DG
Gastroenterol Clin Biol; 2009; 33(10-11):930-9. PubMed ID: 19646834
[TBL] [Abstract][Full Text] [Related]
12. Predictors of nonalcoholic steatohepatitis in patients undergoing bariatric surgery: when is liver biopsy indicated?
Helling TS; Helzberg JH; Nachnani JS; Gurram K
Surg Obes Relat Dis; 2008; 4(5):612-7. PubMed ID: 18226970
[TBL] [Abstract][Full Text] [Related]
13. The effect of the metabolic syndrome, hepatic steatosis and steatohepatitis on liver fibrosis in hereditary hemochromatosis.
Adams LA; Angulo P; Abraham SC; Torgerson H; Brandhagen D
Liver Int; 2006 Apr; 26(3):298-304. PubMed ID: 16584391
[TBL] [Abstract][Full Text] [Related]
14. The effects of 48 weeks of rosiglitazone on hepatocyte mitochondria in human nonalcoholic steatohepatitis.
Caldwell SH; Patrie JT; Brunt EM; Redick JA; Davis CA; Park SH; Neuschwander-Tetri BA
Hepatology; 2007 Oct; 46(4):1101-7. PubMed ID: 17661371
[TBL] [Abstract][Full Text] [Related]
15. MRI findings in nonalcoholic steatohepatitis: correlation with histopathology and clinical staging.
Elias J; Altun E; Zacks S; Armao DM; Woosley JT; Semelka RC
Magn Reson Imaging; 2009 Sep; 27(7):976-87. PubMed ID: 19356874
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with the presence of nonalcoholic steatohepatitis in patients with chronic hepatitis C.
Solis-Herruzo JA; Pérez-Carreras M; Rivas E; Fernández-Vázquez I; Garfia C; Bernardos E; Castellano G; Colina F
Am J Gastroenterol; 2005 May; 100(5):1091-8. PubMed ID: 15842583
[TBL] [Abstract][Full Text] [Related]
17. Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease.
Palekar NA; Naus R; Larson SP; Ward J; Harrison SA
Liver Int; 2006 Mar; 26(2):151-6. PubMed ID: 16448452
[TBL] [Abstract][Full Text] [Related]
18. [Pathology of nonalcoholic steatohepatitis].
Jeen YM; Jin SY
Korean J Hepatol; 2009 Jun; 15(2):122-30. PubMed ID: 19581764
[TBL] [Abstract][Full Text] [Related]
19. Fibrosis heterogeneity in nonalcoholic steatohepatitis and hepatitis C virus needle core biopsy specimens.
Goldstein NS; Hastah F; Galan MV; Gordon SC
Am J Clin Pathol; 2005 Mar; 123(3):382-7. PubMed ID: 15716234
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological study of nonalcoholic fatty liver disease in Japan: the risk factors for fibrosis.
Miyaaki H; Ichikawa T; Nakao K; Yatsuhashi H; Furukawa R; Ohba K; Omagari K; Kusumoto Y; Yanagi K; Inoue O; Kinoshita N; Ishibashi H; Yano M; Eguchi K
Liver Int; 2008 Apr; 28(4):519-24. PubMed ID: 17976158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
